Published in Mediators Inflamm on December 09, 2013
Cell-surface receptors transactivation mediated by g protein-coupled receptors. Int J Mol Sci (2014) 0.93
FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms. Oncotarget (2016) 0.82
The characteristics of thrombin in osteoarthritic pathogenesis and treatment. Biomed Res Int (2014) 0.75
Activation of α2A-adrenergic signal transduction in chondrocytes promotes degenerative remodelling of temporomandibular joint. Sci Rep (2016) 0.75
EGFR is a pivotal regulator of thrombin-mediated inflammation in primary human nucleus pulposus culture. Sci Rep (2017) 0.75
How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol (2001) 14.05
Thrombin signalling and protease-activated receptors. Nature (2000) 9.27
Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum (2001) 5.24
Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun (2005) 3.31
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis (2000) 2.32
Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol (2002) 1.78
Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol (2012) 1.75
Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta (2011) 1.73
Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci (2002) 1.64
The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol (2001) 1.38
Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost (2003) 1.33
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Arthritis Rheum (2010) 1.21
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis (2010) 1.20
Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis (2009) 1.17
Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1- dependent pathway. J Immunol (2009) 1.17
Effect of thrombin inhibition on synovial inflammation in antigen induced arthritis. Ann Rheum Dis (2000) 1.11
New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem (2011) 1.10
Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res (2004) 1.10
Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway. J Cell Physiol (2010) 1.05
Thrombin induces epidermal growth factor receptor transactivation and CCL2 expression in human osteoblasts. Arthritis Rheum (2012) 1.05
Protease-activated receptors: a means of converting extracellular proteolysis into intracellular signals. IUBMB Life (2002) 1.02
Role of the thrombin receptor in restenosis and atherosclerosis. Am J Cardiol (1995) 1.01
Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway. Mol Immunol (2007) 1.00
Ultrasound induces cyclooxygenase-2 expression through integrin, integrin-linked kinase, Akt, NF-kappaB and p300 pathway in human chondrocytes. Cell Signal (2007) 1.00
Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13. Bone (2008) 0.99
Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: a model for extravascular fibrinolysis. Semin Thromb Hemost (1996) 0.97
Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway. Cancer Res (2008) 0.96
Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes. Mol Pharmacol (2007) 0.96
Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor. J Biol Chem (2010) 0.94
Thrombin induces EGF receptor expression and cell proliferation via a PKC(delta)/c-Src-dependent pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2009) 0.94
Thrombin induces heme oxygenase-1 expression in human synovial fibroblasts through protease-activated receptor signaling pathways. Arthritis Res Ther (2012) 0.93
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood (2013) 0.93
Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis. Arthritis Rheum (2008) 0.92
Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblasts. Ann Rheum Dis (1999) 0.91
CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion. Biochim Biophys Acta (2013) 0.88
Thrombin-stimulated proliferation of cultured human synovial fibroblasts through proteolytic activation of proteinase-activated receptor-1. J Pharmacol Sci (2008) 0.82
Termination of tyrphostin AG1478 application results in different recovery of EGF receptor tyrosine residues 1045 and 1173 phosphorylation in A431 cells. Cell Biol Int (2009) 0.81
Developing PAR1 antagonists: minding the endothelial gap. Discov Med (2012) 0.80